Home Dental Radiology Oral chronic graft-versus-host disease – The Journal of the American Dental Association

Oral chronic graft-versus-host disease – The Journal of the American Dental Association

by adminjay


    • Copelan E.A.
    • Chojecki A.
    • Lazarus H.M.
    • Avalos B.R.

    Allogeneic hematopoietic cell transplantation; the current renaissance.

    Blood Rev. 2019; 34: 34-44

    • Schubert M.M.
    • Correa M.E.

    Oral graft-versus-host disease.

    Dent Clin North Am. 2008; 52: 79-109

    • Ion D.
    • Stevenson K.
    • Woo S.B.
    • et al.

    Characterization of oral involvement in acute graft-versus-host disease.

    Biol Blood Marrow Transplant. 2014; 20: 1717-1721

    • Mawardi H.
    • Hashmi S.K.
    • Elad S.
    • Aljurf M.
    • Treister N.

    Chronic graft-versus-host disease: current management paradigm and future perspectives.

    Oral Dis. 2019; 25: 931-948

    • Mays J.W.
    • Fassil H.
    • Edwards D.A.
    • Pavletic S.Z.
    • Bassim C.W.

    Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research.

    Oral Dis. 2013; 19: 327-346

    • Curtis R.E.
    • Metayer C.
    • Rizzo J.D.
    • et al.

    Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study.

    Blood. 2005; 105: 3802-3811

    • Atsuta Y.
    • Suzuki R.
    • Yamashita T.
    • et al.

    Japan Society for Hematopoietic Cell Transplantation. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoi in adults in association with chronic graft-versus-host disease.

    Ann Oncol. 2014; 25: 435-441

    • Samim F.
    • Ten Bohmer K.L.
    • Koppelmans R.G.A.
    • Raber-Durlacher J.E.
    • Epstein J.B.

    Oral care for hematopoietic stem cell transplantation patients: a narrative review.

    Oral Health Prev Dent. 2019; 17: 413-423

    • Passweg J.R.
    • Baldomero H.
    • Basak G.W.
    • et al.

    and for the European Society for Blood and Marrow Transplantation (EBMT). The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies.

    Bone Marrow Transplant. 2019; 54: 1575-1585

    • Shapira M.Y.
    • Tsirigotis P.
    • Resnick I.B.
    • Or R.
    • Abdul-Hai A.
    • Slavin S.

    Allogeneic hematopoietic stem cell transplantation in the elderly.

    Crit Rev Oncol Hematol. 2007; 64: 49-63

    • Ferrara J.L.
    • Levine J.E.
    • Reddy P.
    • Holler E.

    Graft-versus-host disease.

    Lancet. 2009; 373: 1550-1561

    • Goulmy E.
    • Gratama J.W.
    • Blokland E.
    • Zwaan F.E.
    • van Rood J.J.

    A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease.

    Nature. 1983; 302: 159-161

    • Fall-Dickson J.M.
    • Pavletic S.Z.
    • Mays J.W.
    • Schubert M.M.

    Oral complications of chronic graft-versus-host disease.

    J Natl Cancer Inst Monogr. 2019; 2019

  • Classification systems for chronic graft-versus-host disease.

    Blood. 2017; 129: 30-37

    • Lee S.J.
    • Wolff D.
    • Kitko C.
    • et al.

    Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease, IV: the 2014 Response Criteria Working Group report.

    Biol Blood Marrow Transplant. 2015; 21: 984-999

    • Liu D.
    • Ahmet A.
    • Ward L.
    • et al.

    A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy.

    Allergy Asthma Clin Immunol. 2013; 9: 30

    • DePalo J.
    • Chai X.
    • Lee S.J.
    • Cutler C.S.
    • Treister N.

    Assessing the relationship between oral chronic graft-versus-host disease and global measures of quality of life.

    Oral Oncol. 2015; 51: 944-949

    • Carpenter P.A.
    • Kitko C.L.
    • Elad S.
    • et al.

    National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease, V: the 2014 Ancillary Therapy and Supportive Care Working Group report.

    Biol Blood Marrow Transplant. 2015; 21: 1167-1187

    • Meier J.K.
    • Wolff D.
    • Pavletic S.
    • et al.

    Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD.

    Clin Oral Investig. 2011; 15: 127-139

    • Imanguli M.M.
    • Atkinson J.C.
    • Mitchell S.A.
    • et al.

    Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation.

    Biol Blood Marrow Transplant. 2010; 16: 1362-1369

    • Balasubramaniam R.
    • Alawi F.
    • DeRossi S.

    Superficial mucoceles in chronic graft-versus-host disease: a case report and review of the literature.

    Gen Dent. 2009; 57: 82-88

    • Epstein J.B.
    • de Andrade E.S.S.M.
    • Epstein G.L.
    • Leal J.H.S.
    • Barasch A.
    • Smutzer G.

    Taste disorders following cancer treatment: report of a case series.

    Support Care Cancer. 2019; 27: 4587-4595

    • Hull K.M.
    • Kerridge I.
    • Schifter M.

    Long-term oral complications of allogeneic haematopoietic SCT.

    Bone Marrow Transplant. 2012; 47: 265-270

    • Bassim C.W.
    • Fassil H.
    • Mays J.W.
    • et al.

    Oral disease profiles in chronic graft versus host disease.

    J Dent Res. 2015; 94: 547-554

    • Shahrabi Farahani S.
    • Treister N.S.
    • Khan Z.
    • Woo S.B.

    Oral verruciform xanthoma associated with chronic graft-versus-host disease: a report of five cases and a review of the literature.

    Head Neck Pathol. 2011; 5: 193-198

    • Elad S.
    • Meyerowitz C.
    • Shapira M.Y.
    • Glick M.
    • Bitan M.
    • Amir G.

    Oral posttransplantation lymphoproliferative disorder: an uncommon site for an uncommon disorder.

    Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 105: 59-64

    • Curtis R.E.
    • Rowlings P.A.
    • Deeg H.J.
    • et al.

    Solid cancers after bone marrow transplantation.

    N Engl J Med. 1997; 336: 897-904

    • Rizzo J.D.
    • Curtis R.E.
    • Socié G.
    • et al.

    Solid cancers after allogeneic hematopoietic cell transplantation.

    Blood. 2009; 113: 1175-1183

    • Demarosi F.
    • Lodi G.
    • Carrassi A.
    • Soligo D.
    • Sardella A.

    Oral malignancies following HSCT: graft versus host disease and other risk factors.

    Oral Oncol. 2005; 41: 865-877

    • Mawardi H.
    • Elad S.
    • Correa M.E.
    • et al.

    Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes.

    Bone Marrow Transplant. 2011; 46: 884-891

    • de Oliveira M.A.
    • Martins E.M.F.
    • Wang Q.
    • et al.

    Clinical presentation and management of mTOR inhibitor-associated stomatitis.

    Oral Oncol. 2011; 47: 998-1003

    • Vigarios E.
    • Beylot-Barry M.
    • Jegou M.-H.
    • Oberic L.
    • Ysebaert L.
    • Sibaud V.

    Dose-limiting stomatitis associated with ibrutinib therapy: a case series.

    Br J Haematol. 2019; 185: 784-788

    • Kumar S.
    • Guliani A.
    • Vinay K.

    Cyclosporine-induced gingival hypertrophy.

    JAMA Dermatol. 2019; 155: 487

    • Lalla R.V.
    • Latortue M.C.
    • Hong C.H.
    • et al.

    and Fungal Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of oral fungal infections in patients receiving cancer therapy.

    Support Care Cancer. 2010; 18: 985-992

    • Haverman T.M.
    • Raber-Durlacher J.E.
    • Rademacher W.M.
    • et al.

    Oral complications in hematopoietic stem cell recipients: the role of inflammation.

    Mediators Inflamm. 2014; 2014: 378281

    • Ruggiero S.L.
    • Dodson T.B.
    • Fantasia J.
    • et al.

    American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw: 2014 update.

    J Oral Maxillofac Surg. 2014; 72: 1938-1956

    • Treister N.
    • Duncan C.
    • Cutler C.
    • Lehmann L.

    How we treat oral chronic graft-versus-host disease.

    Blood. 2012; 120: 3407-3418

    • Treister N.
    • Chai X.
    • Kurland B.
    • et al.

    Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium.

    Bone Marrow Transplant. 2013; 48: 1123-1128

    • Elad S.
    • Zinchuk K.
    • Li S.
    • Cutler C.
    • Liesveld J.
    • Treister N.S.

    Economic and practical considerations in the treatment of oral mucosal chronic graft-versus-host disease.

    Biol Blood Marrow Transplant. 2018; 24: 1748-1753

    • Zadik Y.
    • Elad S.
    • Shapira A.
    • Shapira M.Y.

    Treatment of oral mucosal manifestations of chronic graft-versus-host disease: dexamethasone vs. budesonide.

    Expert Opin Pharmacother. 2017; 18: 235-242

    • Epstein J.B.
    • Raber-Durlacher J.E.
    • Lill M.
    • et al.

    Photobiomodulation therapy in the management of chronic oral graft-versus-host disease.

    Support Care Cancer. 2017; 25: 357-364

    • Elad S.
    • Or R.
    • Shapira M.Y.
    • et al.

    CO2 laser in oral graft-versus-host disease: a pilot study.

    Bone Marrow Transplant. 2003; 32: 1031-1034

    • Elad S.
    • Raber-Durlacher J.E.
    • Brennan M.T.
    • et al.

    Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the Joint Task Force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT).

    Support Care Cancer. 2015; 23: 223-236

    • Wolff A.
    • Joshi R.K.
    • Ekstrom J.
    • et al.

    A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: a systematic review sponsored by the World Workshop on Oral Medicine VI.

    Drugs R D. 2017; 17: 1-28

  • Sialometrical and sialochemical analysis of patients with chronic graft-versus-host disease: a prolonged study.

    Cancer Invest. 2003; 21: 34-40

  • Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study.

    Bone Marrow Transplant. 1999; 23: 1007-1011

    • Alajbeg I.
    • Falcão D.P.
    • Tran S.D.
    • et al.

    Intraoral electrostimulator for xerostomia relief: a long-term, multicenter, open-label, uncontrolled, clinical trial.

    Oral Surg Oral Med Oral Pathol Oral Radiol. 2012; 113: 773-781

    • Castellarin P.
    • Stevenson K.
    • Biasotto M.
    • Yuan A.
    • Woo S.B.
    • Treister N.S.

    Extensive dental caries in patients with oral chronic graft-versus-host disease.

    Biol Blood Marrow Transplant. 2012; 18: 1573-1579

  • Remineralization therapies for initial caries lesions.

    Curr Oral Health Rep. 2015; 2: 95-101

    • Rademacher W.M.H.
    • Aziz Y.
    • Hielema A.
    • et al.

    Oral adverse effects of drugs: taste disorders.

    Oral Dis. 2020; 26: 213-223

    • Brisbois T.D.
    • de Kock I.H.
    • Watanabe S.M.
    • et al.

    Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial.

    Ann Oncol. 2011; 22: 2086-2093

    • Epstein J.B.
    • Raber-Durlacher J.E.
    • Huysmans M.C.
    • et al.

    Photobiomodulation therapy alleviates tissue fibroses associated with chronic graft-versus-host disease: two case reports and putative anti-fibrotic roles of TGF-β.

    Photomed Laser Surg. 2018; 36: 92-99

    • Baird K.
    • Cooke K.
    • Schultz K.R.

    Chronic graft-versus-host disease (GVHD) in children.

    Pediatr Clin North Am. 2010; 57: 297-322

    • Treister N.S.
    • Woo S.B.
    • O’Holleran E.W.
    • Lehmann L.E.
    • Parsons S.K.
    • Guinan E.C.

    Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation.

    Biol Blood Marrow Transplant. 2005; 11: 721-731

    • Majorana A.
    • Schubert M.M.
    • Porta F.
    • Ugazio A.G.
    • Sapelli P.L.

    Oral complications of pediatric hematopoietic cell transplantation: diagnosis and management.

    Support Care Cancer. 2000; 8: 353-365

    • Mester A.
    • Irimie A.I.
    • Tanase A.
    • et al.

    Periodontal disease might be a risk factor for graft versus host disease: a systematic review.

    Crit Rev Oncol Hematol. 2020; 147: 102878



  • Source link

    Related Articles

    Leave a Comment